BeiGene, a biotechnology company, and DualityBio, an antibody drug conjugate (ADC) organization, announced a deal for the biotech to acquire an exclusive option for a global clinical and commercial ...

The ongoing expansion of our state-of-the-art manufacturing base, cofinanced by Sanofi, will support launch of PCV21 and future next generation vaccines,” said Jaeyong Ahn, CEO, president, SK ...